Atea Pharmaceuticals, Inc. (AVIR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $116k
- Nov 19 · No plan
- Form 4 sales
- 14
- On record
- Form 144 notices
- 15
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeDec 10, 2024 2024
Filed to sell 359,606 shares ($1M)
Berger Franklin M, Lead Independent Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 saleUnusualDec 10, 2024 same day
Sold 359,606 shares at $2.85 ($1M)
Berger Franklin M, Director
No 10b5-1 planSold 44.3% of holdings ($2.3M position)451,897 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 noticeNoticeNov 18, 2026 +708 days
Filed to sell 18,252 shares ($72k)
Polsky Bruce, Director
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 saleNo planNov 18, 2026 same day
Sold 41,226 shares at $4.08 ($168k)
Polsky Bruce, Director
No 10b5-1 planSold 20.6% of holdings ($815k position)158,580 shares leftFirst sale on recordFiling
- 5 Form 144 noticeNoticeNov 19, 2026 +1 day
Filed to sell 8,750 shares ($35k)
Polsky Bruce, Director
No 10b5-1 planFirst sale on recordFiling
- 6 Form 144 noticeNoticeNov 19, 2026 same day
Filed to sell 22,619 shares ($89k)
Lucidi Bruno, Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 saleNo planNov 19, 2026 same day
Sold 8,750 shares at $4.03 ($35k)
Polsky Bruce, Director
No 10b5-1 planSold 5.5% of holdings ($640k position)149,830 shares leftFollows a Form 144Filing
- 8 Form 4 saleNo planNov 19, 2026 same day
Sold 29,360 shares at $3.96 ($116k)
Lucidi Bruno, Director
No 10b5-1 planSold 13.5% of holdings ($862k position)187,990 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (29)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | Nov 19, 2026 | Lucidi Bruno | AVIR | Director | Form 4 sale | 29,360 | $116k | 13.5% | No plan | SEC |
| Nov 19, 2026 | Nov 19, 2026 | Polsky Bruce | AVIR | Director | Form 4 sale | 8,750 | $35k | 5.5% | No plan | SEC |
| Nov 19, 2026 | Nov 19, 2026 | Lucidi Bruno | AVIR | Director | Form 144 notice | 22,619 | $89k | Notice | SEC | |
| Nov 19, 2026 | Nov 19, 2026 | Polsky Bruce | AVIR | Director | Form 144 notice | 8,750 | $35k | Notice | SEC | |
| Nov 18, 2026 | Nov 18, 2026 | Polsky Bruce | AVIR | Director | Form 4 sale | 41,226 | $168k | 20.6% | No plan | SEC |
| Nov 18, 2026 | Nov 18, 2026 | Polsky Bruce | AVIR | Director | Form 144 notice | 18,252 | $72k | Notice | SEC | |
| Dec 10, 2024 | Dec 12, 2024 | Berger Franklin M | AVIR | Director | Form 4 sale | 359,606 | $1M | 44.3% | Unusual | SEC |
| Dec 10, 2024 | Dec 10, 2024 | Berger Franklin M | AVIR | Lead Independent Director | Form 144 notice | 359,606 | $1M | Notice | SEC | |
| Sep 19, 2024 | Sep 19, 2024 | Sommadossi Jean-Pierre | AVIR | President, CEO, and Chairman | Form 4 sale | 57,969 | $234k | 1.0% | Routine | SEC |
| Sep 19, 2024 | Sep 19, 2024 | JPM Partners LLC | AVIR | Affiliate | Form 144 notice | 1,841 | $7k | Notice | SEC | |
| Sep 18, 2024 | Sep 18, 2024 | JPM Partners LLC | AVIR | Affiliate | Form 144 notice | 22,187 | $89k | Notice | SEC | |
| Sep 17, 2024 | Sep 17, 2024 | JPM Partners LLC | AVIR | Affiliate | Form 144 notice | 33,941 | $137k | Notice | SEC | |
| Jun 20, 2024 | Jun 21, 2024 | Polsky Bruce | AVIR | Director | Form 4 sale | 17,544 | $61k | 21.1% | No plan | SEC |
| Jun 20, 2024 | Jun 20, 2024 | Polsky Bruce | AVIR | Director | Form 144 notice | 17,544 | $69k | Notice | SEC | |
| Jun 5, 2024 | Jun 7, 2024 | Sommadossi Jean-Pierre | AVIR | President, CEO, and Chairman | Form 4 sale | 1,006 | $4k | 0.0% | Routine | SEC |
| Jun 5, 2024 | Jun 5, 2024 | JPM Partners LLC | AVIR | Affiliate | Form 144 notice | 1,006 | $4k | Notice | SEC | |
| Feb 1, 2024 | Feb 2, 2024 | Corcoran Andrea | AVIR | Officer | Form 4 sale | 15,843 | $61k | 2.3% | No plan | SEC |
| Feb 1, 2024 | Feb 2, 2024 | Sommadossi Jean-Pierre | AVIR | President, CEO, and Chairman | Form 4 sale | 56,910 | $219k | 32.8% | Routine | SEC |
| Feb 1, 2024 | Feb 2, 2024 | Horga Maria Arantxa | AVIR | Chief Medical Officer | Form 4 sale | 15,870 | $61k | 38.2% | Unusual | SEC |
| Feb 1, 2024 | Feb 2, 2024 | Foster Wayne | AVIR | EVP, Chief Accounting Officer | Form 4 sale | 12,477 | $48k | 37.4% | Unusual | SEC |
| Feb 1, 2024 | Feb 2, 2024 | Vavricka John | AVIR | Chief Commercial Officer | Form 4 sale | 11,819 | $45k | 35.5% | Unusual | SEC |
| Feb 1, 2024 | Feb 2, 2024 | Hammond Janet MJ | AVIR | Chief Development Officer | Form 4 sale | 14,029 | $54k | 28.4% | Unusual | SEC |
| Feb 1, 2024 | Feb 1, 2024 | Foster Wayne | AVIR | EVP, Chief Accounting Officer | Form 144 notice | 14,311 | $58k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | Sommadossi Jean-Pierre | AVIR | President, CEO, and Chairman | Form 144 notice | 65,476 | $266k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | Hammond Janet MJ | AVIR | Chief Development Officer | Form 144 notice | 16,110 | $66k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | Corcoran Andrea | AVIR | CFO, EVP, Legal and Secretary | Form 144 notice | 18,198 | $74k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | Vavricka John | AVIR | Chief Commercial Officer | Form 144 notice | 13,552 | $55k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | Horga Maria Arantxa | AVIR | Chief Medical Officer | Form 144 notice | 18,227 | $74k | Notice | SEC | |
| Nov 14, 2022 | Nov 15, 2022 | Berger Franklin M | AVIR | Director | Form 4 sale | 41,666 | $215k | 5.1% | Plan not stated | SEC |